Stocks and Investing Stocks and Investing
Thu, November 4, 2021

Frank Morgan Maintained (AMED) at Buy with Decreased Target to $221 on, Nov 4th, 2021


Published on 2024-10-27 18:30:14 - WOPRAI, Frank Morgan
  Print publication without navigation


Frank Morgan of RBC Capital, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $244 to $221 on, Nov 4th, 2021.

Frank has made no other calls on AMED in the last 4 months.



There are 8 other peers that have a rating on AMED. Out of the 8 peers that are also analyzing AMED, 2 agree with Frank's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gary Taylor of "Cowen & Co." Initiated at Hold and Held Target at $195 on, Friday, September 10th, 2021
  • Joanna Gajuk of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $220 on, Thursday, August 5th, 2021


These are the ratings of the 6 analyists that currently disagree with Frank


  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $225 on, Wednesday, November 3rd, 2021
  • David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $190 on, Wednesday, October 13th, 2021
  • Andrew Mok of "UBS" Initiated at Strong Sell and Held Target at $150 on, Friday, September 24th, 2021
  • A.J. Rice of "Credit Suisse" Maintained at Buy with Decreased Target to $250 on, Wednesday, August 11th, 2021
  • John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $250 on, Tuesday, August 10th, 2021
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $235 on, Tuesday, August 10th, 2021
Contributing Sources